Suchergebnisse - "Shao, Jingwei"

PubPharm (7)

1

Sex-related pharmacokinetic differences and mechanisms of metapristone (RU486 metabolite)

enthalten in: Scientific reports | 2017

von Chen, W. | Xiao, Y. | Chen, J. | +10

2

Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2017

von Zheng, G. | Shen, Z. | Chen, H. | +5

ErratumIn: Biomed Pharmacother. 2018 Feb;98 :925-926. - PMID 29421862

3

In vitro and in vivo efficacy and safety evaluation of metapristone and mifepristone as cancer metastatic chemopreventive agents

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2016

von Wang, J. | Chen, J. | Zhu, Y. | +9

4

Aspirin, lysine, mifepristone and doxycycline combined can effectively and safely prevent and treat cancer metastasis : prevent seeds from gemmating on soil

enthalten in: Oncotarget | 2015

von Wan, L. | Dong, H. | Xu, H. | +13

5

Systems pharmacology of mifepristone (RU486) reveals its 47 hub targets and network : comprehensive analysis and pharmacological focus on FAK-Src-Paxillin complex

enthalten in: Scientific reports | 2015

von Yu, S. | Yang, X. | Zhu, Y. | +10

6

The unique pharmacological characteristics of mifepristone (RU486) : from terminating pregnancy to preventing cancer metastasis

enthalten in: Medicinal research reviews | 2014

von Chen, J. | Wang, J. | Shao, J. | +5

7

Synthesis, spectral characterization, and in vitro cellular activities of metapristone, a potential cancer metastatic chemopreventive agent derived from mifepristone (RU486)

enthalten in: The AAPS journal | 2014

von Wang, J. | Chen, J. | Wan, L. | +7

1
[1]